Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Selling and Marketing Expense : ¥1,549 Mil (TTM As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Tibet Rhodiola Pharmaceutical Holding Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Tibet Rhodiola Pharmaceutical Holding Co's Selling and Marketing Expense for the three months ended in Mar. 2025 was ¥387 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1,549 Mil.

Tibet Rhodiola Pharmaceutical Holding Co Selling and Marketing Expense Historical Data

The historical data trend for Tibet Rhodiola Pharmaceutical Holding Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Rhodiola Pharmaceutical Holding Co Selling and Marketing Expense Chart

Tibet Rhodiola Pharmaceutical Holding Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Selling and Marketing Expense

Get a 7-Day Free Trial

677.14

1,146.91

1,400.52

1,746.98

1,556.62

Tibet Rhodiola Pharmaceutical Holding Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Selling and Marketing Expense	Get a 7-Day Free Trial															395.24	509.79	307.48	344.12	387.36

Tibet Rhodiola Pharmaceutical Holding Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,549 Mil.

Tibet Rhodiola Pharmaceutical Holding Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Tibet Rhodiola Pharmaceutical Holding Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Rhodiola Pharmaceutical Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) » Definitions » Selling and Marketing Expense

Traded in Other Exchanges

N/A

Address

No. 93, Beijing Middle Road, Tibet Autonomous Region, Lhasa, CHN, 610023

Website

http://www.xzyy.cn

Tibet Rhodiola Pharmaceutical Holding Co is a Chinese company producing biological products and traditional Tibetan medicines.

Executives

Wang Bao Ming	senior management
Peng Hui	Director
Cao Shu Zhen	senior management
Si Qin	Director
Ren Bei Chen	Supervisors
Liu De Gong	Supervisors
Gao Zi Li	senior management
Zhou Ming De	senior management
Chen Li Ye	senior management
Lin Ben	Director
Chen Da Bin	Director

Tibet Rhodiola Pharmaceutical Holding Co Headlines

No Headlines